1802 - T-Guard in SR-aGVHD

Go Back to BMT CTN Protocol Listing

  • Protocol Short Name and Number: T-Guard for SR aGVHD, 1802
  • Protocol Long Name: An Open-Label, Single-Arm, Multicenter Study of Combination anti- CD3/CD7 Immunotoxin (T-Guard) for Steroid-Refractory Acute Graft- versus-Host Disease
  • Protocol Synopsis (PDF)
  • Key Personnel
    • BMT CTN # 1802 Co-Chair: John Levine, MD
    • BMT CTN # 1802 Co-Chair: Gabrielle Meyers, MD
    • BMT CTN # 1802 Protocol Officer: Mehdi Hamadani, MD
  • Keywords: T-Guard, TGuard, Graft versus Host Disease, Graft vs. Host Disease, GVHD, Xenikos, Anti-CD3/CD7 Immunotoxin, GVHD Treatment, Pediatric, Child, Children, Teen, Adolescent